These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND ERBB4, MGC138404, 2066, ENSG00000178568, Q15303, p180erbB4, HER4
85 results:

  • 1. Targeted panel sequencing of pharmacogenes and oncodrivers in colorectal cancer patients reveals genes with prognostic significance.
    Heczko L; Liška V; Vyčítal O; Fiala O; Šůsová S; Hlaváč V; Souček P
    Hum Genomics; 2024 Jul; 18(1):83. PubMed ID: 39030589
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Nuclear Softness Promotes the Metastatic Potential of Large-Nucleated colorectal cancer Cells via the erbb4-Akt1-Lamin A/C Signaling Pathway.
    Li Y; Li Q; Mu L; Hu Y; Yan C; Zhao H; Mi Y; Li X; Tao D; Qin J
    Int J Biol Sci; 2024; 20(7):2748-2762. PubMed ID: 38725859
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis.
    Lu X; Li Y; Li Y; Zhang X; Shi J; Feng H; Yu Z; Gao Y
    BMC Cancer; 2023 Nov; 23(1):1117. PubMed ID: 37974093
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort study.
    Wang J; Xiu J; Farrell A; Baca Y; Arai H; Battaglin F; Kawanishi N; Soni S; Zhang W; Millstein J; Shields AF; Grothey A; Weinberg BA; Marshall JL; Lou E; Khushman M; Sohal DPS; Hall MJ; Liu T; Oberley M; Spetzler D; Korn WM; Shen L; Lenz HJ
    Lancet Oncol; 2023 Feb; 24(2):151-161. PubMed ID: 36681091
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. erbb4-encoded novel miRNAs act as tumor suppressors by regulating ErbB/PI3K signaling.
    Ghaemi Z; Soltani BM; Mowla SJ
    Tumour Biol; 2022; 44(1):215-230. PubMed ID: 36442170
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract.
    Wu H; Yu Z; Liu Y; Guo L; Teng L; Guo L; Liang L; Wang J; Gao J; Li R; Yang L; Nie X; Su D; Liang Z
    Cancer Commun (Lond); 2022 Dec; 42(12):1367-1386. PubMed ID: 36264285
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The HER family as therapeutic targets in colorectal cancer.
    Ye P; Wang Y; Li R; Chen W; Wan L; Cai P
    Crit Rev Oncol Hematol; 2022 Jun; 174():103681. PubMed ID: 35462030
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Diagnosis and Treatment of ERBB2-Positive Metastatic colorectal cancer: A Review.
    Strickler JH; Yoshino T; Graham RP; Siena S; Bekaii-Saab T
    JAMA Oncol; 2022 May; 8(5):760-769. PubMed ID: 35238866
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Multi-OMICs data analysis identifies molecular features correlating with tumor immunity in colon cancer.
    Elsayed I; Elsayed N; Feng Q; Sheahan K; Moran B; Wang X
    Cancer Biomark; 2022; 33(2):261-271. PubMed ID: 35213358
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A genome-wide search for determinants of survival in 1926 patients with advanced colorectal cancer with follow-up in over 22,000 patients.
    Wills C; He Y; Summers MG; Lin Y; Phipps AI; Watts K; Law PJ; Al-Tassan NA; Maughan TS; Kaplan R; Houlston RS; Peters U; Newcomb PA; Chan AT; Buchanan DD; Gallinger S; Marchand LL; Pai RK; Shi Q; Alberts SR; Gray V; West HD; Escott-Price V; Dunlop MG; Cheadle JP
    Eur J Cancer; 2021 Dec; 159():247-258. PubMed ID: 34794066
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Anti‑HER3 monoclonal antibody exerts antitumor activity in a mouse model of colorectal adenocarcinoma.
    Asano T; Ohishi T; Takei J; Nakamura T; Nanamiya R; Hosono H; Tanaka T; Sano M; Harada H; Kawada M; Kaneko MK; Kato Y
    Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34184091
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Validity of claims-based algorithms for selected cancers in Japan: Results from the VALIDATE-J study.
    de Luise C; Sugiyama N; Morishima T; Higuchi T; Katayama K; Nakamura S; Chen H; Nonnenmacher E; Hase R; Jinno S; Kinjo M; Suzuki D; Tanaka Y; Setoguchi S
    Pharmacoepidemiol Drug Saf; 2021 Sep; 30(9):1153-1161. PubMed ID: 33960542
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Healthy lifestyles, genetic modifiers, and colorectal cancer risk: a prospective cohort study in the UK Biobank.
    Choi J; Jia G; Wen W; Shu XO; Zheng W
    Am J Clin Nutr; 2021 Apr; 113(4):810-820. PubMed ID: 33675346
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Löwenstein-Buschke: Clinicopathologic Analysis of 78 Cases of Large and Giant Condyloma Acuminata of the Anus.
    Taskin OC; Pehlivanoglu B; Reid MD; Friedman T; Lee M; Tadros TS; Bandyopadhyay S; Akinfolarin J; Armutlu A; Basturk O; Adsay V
    Turk Patoloji Derg; 2021; 37(1):18-25. PubMed ID: 33021736
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. her4 promotes the progression of colorectal cancer by promoting epithelial‑mesenchymal transition.
    Jia X; Wang H; Li Z; Yan J; Guo Y; Zhao W; Gao L; Wang B; Jia Y
    Mol Med Rep; 2020 Apr; 21(4):1779-1788. PubMed ID: 32319604
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The role of erbb4 in cancer.
    Segers VFM; Dugaucquier L; Feyen E; Shakeri H; De Keulenaer GW
    Cell Oncol (Dordr); 2020 Jun; 43(3):335-352. PubMed ID: 32219702
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Mechanistic insights into differential requirement of receptor dimerization for oncogenic activation of mutant EGFR and its clinical perspective.
    Cho J
    BMB Rep; 2020 Mar; 53(3):133-141. PubMed ID: 32172728
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Multi-region sequencing unveils novel actionable targets and spatial heterogeneity in esophageal squamous cell carcinoma.
    Yan T; Cui H; Zhou Y; Yang B; Kong P; Zhang Y; Liu Y; Wang B; Cheng Y; Li J; Guo S; Xu E; Liu H; Cheng C; Zhang L; Chen L; Zhuang X; Qian Y; Yang J; Ma Y; Li H; Wang F; Liu J; Liu X; Su D; Wang Y; Sun R; Guo S; Li Y; Cheng X; Liu Z; Zhan Q; Cui Y
    Nat Commun; 2019 Apr; 10(1):1670. PubMed ID: 30975989
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Functional Analysis of Somatic Mutations Affecting Receptor Tyrosine Kinase Family in Metastatic colorectal cancer.
    Duplaquet L; Figeac M; Leprêtre F; Frandemiche C; Villenet C; Sebda S; Sarafan-Vasseur N; Bénozène M; Vinchent A; Goormachtigh G; Wicquart L; Rousseau N; Beaussire L; Truant S; Michel P; Sabourin JC; Galateau-Sallé F; Copin MC; Zalcman G; De Launoit Y; Fafeur V; Tulasne D
    Mol Cancer Ther; 2019 Jun; 18(6):1137-1148. PubMed ID: 30926633
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Clinical significance of multiple gene detection with a 22-gene panel in formalin-fixed paraffin-embedded specimens of 207 colorectal cancer patients.
    Gao XH; Yu GY; Hong YG; Lian W; Chouhan H; Xu Y; Liu LJ; Bai CG; Zhang W
    Int J Clin Oncol; 2019 Feb; 24(2):141-152. PubMed ID: 30612269
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.